Structure via PubChem · Public domain (PubChem)
butabarbital
Sign in to saveAlso known as Butisol®, 5-sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)barbituric acid, 5-sec-butyl-5-ethylbarbituric acid, secbutabarbital, Butisol, 5-sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione
Butabarbital (brand name Butisol) is a prescription barbiturate sleep aid and anxiety medication. Butabarbital has a particularly fast onset of effects and short duration of action compared to other barbiturates, which makes it useful for certain applications such as treating severe insomnia, relieving general anxiety and relieving anxiety before surgical procedures; however it is also relatively dangerous particularly when combined with alcohol, and so is now rarely used, although it is still prescribed in some Eastern European and South American countries. Its intermediate duration of action
Key facts
- Drug.verifiedrevid
- 443491373
- Drug.IUPAC_name
- 5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione
- Drug.image
- Butabarbital.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 120
- Drug.tradename
- Butisol
- Drug.MedlinePlus
- a682417
- Drug.DailyMedID
- Butabarbital
- Drug.legal_BR
- B1
- Drug.legal_CA
- Schedule IV
- Drug.legal_US
- Schedule III
- Drug.legal_DE
- Anlage II
- Drug.elimination_half life
- 100 hours
- Drug.excretion
- Urine
- Drug.IUPHAR_ligand
- 7137 <!--
- Drug.CASNo_Ref
- -->
- Drug.CAS_number
- 125-40-6
- Drug.ATC_prefix
- none
via Wikipedia infobox
Chemical data
- Formula
- C10H16N2O3
- Molecular weight
- 212.25 g/mol
- IUPAC name
- 5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione
- SMILES
- CCC(C)C1(C(=O)NC(=O)NC1=O)CC
- InChIKey
- ZRIHAIZYIMGOAB-UHFFFAOYSA-N
- XLogP
- 1.6
- Polar surface area
- 75.3 Ų
- H-bond donors
- 2
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1939
- Admin. routes
- oral
via ChEMBL · EBI
Research
62 papers- Butabarbital.2006
- Analysis of Barbiturates in Urine by LC-MS/MS.Methods in molecular biology (Clifton, N.J.) · 2024
- Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital.Journal of clinical psychopharmacology · 2003
- Butabarbital sodium and chlordiazepoxide in anxious neurotic outpatients: a collaborative controlled study.Clinical pharmacology and therapeutics · 1970
- Comparison of anaesthetic and kinetic properties of thiobutabarbital, butabarbital and hexobarbital after intravenous threshold doses in the male rat.Pharmacology & toxicology · 1989
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 212.116092
- Has use
- medication
Show 6 more facts
via Wikidata · CC0
~6 min read
Encyclopedic overview
13 sectionsContents
- History
- Clinical uses
- Administration
- Clinical effects & elimination
- Overdose & abuse
- Side effects
- Adverse effects
- Contradictions
- Pharmacology
- Absorption, distribution and excretion
- Mechanism of action
- References
- External links
Butabarbital (brand name Butisol) is a prescription barbiturate sleep aid and anxiety medication. Butabarbital has a particularly fast onset of effects and short duration of action compared to other barbiturates, which makes it useful for certain applications such as treating severe insomnia, relieving general anxiety and relieving anxiety before surgical procedures; however it is also relatively dangerous particularly when combined with alcohol, and so is now rarely used, although it is still prescribed in some Eastern European and South American countries. Its intermediate duration of action gives butabarbital an abuse potential slightly lower than secobarbital. Butabarbital can be hydrolyzed to valnoctamide.
{| class="wikitable" style="text-align:center" |+ Stereoisomeres of butabarbital |- | class=skin-invert-image|120px || class=skin-invert-image|120px |- | (R)-Stereoisomer || (S)-Stereoisomer |}
Excerpted from Wikipedia’s “butabarbital” article, available under the CC BY-SA 4.0 licence.
Gallery (3)
Available in 14 languages
- Deutsch
- Português
- Bahasa Indonesia
- Croatian
- Finnish
- Galician
- Polski
- Romanian
- Serbian
- Serbian (Latin)
- Tiếng Việt
- Welsh
- فارسی
via Wikidata sitelinks · CC0